| Title
|
Type
|
Submission Type |
Organizer |
Cosponsor |
Description |
| General Posters |
Poster |
Contributed |
|
|
|
| Sci-Mix |
Poster |
Contributed |
|
|
|
| Academic Drug Discovery |
Oral |
Invited |
|
|
|
| Besides Off Rate: The Importance of On Rate & Target Rebinding |
Oral |
Invited |
|
|
|
| Covalent Inhibition beyond Cysteine |
Oral |
Invited |
|
|
|
| Exploring Cryptic Pockets |
Oral |
Invited |
|
|
|
| First Time Disclosure of Clinical Candidates |
Oral |
Invited |
|
|
|
| General Orals |
Oral |
Contributed |
|
|
|
| Ions Count: Acids, Bases & Zwitterionics in Drug Design (Medicinal Chemists' Toolbox Series) |
Oral |
Invited |
|
|
|
| MEDI Awards Symposium |
Oral |
Invited |
|
|
|
| Recent Advances in Targeting Oncogenic KRAS |
Oral |
Invited |
|
|
|
| Small Molecule Immunomodulators in Cancer |
Oral |
Invited |
|
|
|
| Small Molecule Therapeutics for Neuro-oncology |
Oral |
Invited |
|
|
|
| Synthetic Technologies to Enable Medicinal Chemistry |
Oral |
Invited |
|
|
|
| Targeted Protein Degradation: A Small Molecule Game-Changer for Medicine Discovery |
Oral |
Invited |
|
|
|
| The Messy Business of Target (In)Validation: Chemistry's Role & Challenges in Early Discovery |
Oral |
Invited |
|
|
|
| Therapeutic Developments in Health Disparities |
Oral |
Invited |
|
|
|
